P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO-T TRIAL PET/CT SUBSTUDY. (23rd June 2022) - Gleeson, M.; Arias, C.; Cunningham, D.; Peckitt, C.; Du, Y.; Hujairi, N.; To, Y. M.; Chen, H.-C.; Patel, S.; Chau, I.; Johnson, P.; Ardeshna, K. M.; et al.